PMID: Summary Keywords autoimmune diseases, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, incretin-based therapy, psoriasis, real-world evidence Citation Chiang Y-L, Li T-H, Fang Y-W, Liu Y-F, Wu J and Tsai M-H (2026) Dermatologic outcomes associated with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a large-scale target trial emulation
10.2174/2211352513666150318234624 34 BerheH.Kumar Cinthakunta SridharM.ZerihunM.QvitN
Physical Therapy and Targeted Exercises Physical therapy remains one of the most effective long-term solutions for sciatica
Este protocolo estricto es esencial para optimizar la absorcin
Differences in dosing schedules, potency, receptor affinity, and pharmacokinetic profiles help explain these variations in clinical outcomes
Efectos gastrointestinales: Las nuseas son el efecto secundario ms comn, afectando aproximadamente al 20-40% de los pacientes segn los estudios clnicos, con mayor incidencia durante la titulacin inicial y los aumentos de dosis
